Aug 2026· Frontiers in Genetics· Vol 17· 0 citations· 39 references
Medicine
TL;DR
The findings expand the genotypic and phenotypic spectrum of DEE96, demonstrating that DEE96 manifests as a multisystem disorder with prenatal onset, and supports considering NSF variants in the differential diagnosis of complex fetal syndromes with neurological and hematological abnormalities.
Abstract
Background Developmental and epileptic encephalopathy 96 (DEE96, OMIM 619340) is a rare autosomal dominant disorder caused by heterozygous variants in the NSF gene, encoding a key AAA + ATPase involved in SNARE-mediated membrane fusion. To date, only four pathogenic variants have been reported. Methods Trio whole-exome-sequencing and Sanger validation were performed in a fetus presenting with multiple prenatal anomalies. Bioinformatic analyses and literature review were conducted to characterize genotype-phenotype correlations. Results We identified a novel de novo heterozygous missense variant [c.1055 A>G; p (Asn352Ser)] in the D1 domain of NSF, classified as likely pathogenic per ACMG/AMP criteria. Prenatal ultrasound revealed increased nuchal fold thickness, left clubfoot, severe anemia with cardiac enlargement, and hepatosplenomegaly. Increased nuchal fold thickness and left clubfoot had not been previously documented in DEE96 cases. This represents the second prenatal diagnosis and fifth case overall. Conclusion Our findings expand the genotypic and phenotypic spectrum of DEE96, demonstrating that DEE96 manifests as a multisystem disorder with prenatal onset. The high incidence of severe anemia suggests hematological involvement may be a characteristic feature. These observations support considering NSF variants in the differential diagnosis of complex fetal syndromes with neurological and hematological abnormalities.
This case expands the clinical spectrum associated with RFX3 variants, supporting a potential role in IESS and early neurodevelopmental disruption, and highlights the relevance of including RFX3 in the genetic evaluation of patients with IESS and co-occurring neurodevelopmental disorders.
Graziana Ceraolo, Giulia Spoto, M. Trivisano et al.· International Journal of Mol...· 0 citations
A pooled analysis delineates the phenotypic spectrum of ALG13-related epilepsy and emphasizes the prominence of the N107S hotspot variant, which is associated with more severe neurodevelopmental outcomes.
Song Su, Wenchao Zhang, Ying Ren et al.· Seizure· 0 citations
The findings support a possible domain‐related genotype–phenotype association for the role of ALG13 in neurodevelopmental disorders and provide additional developmental context for the role of ALG13 in neurodevelopmental disorders.
Song Su, Wandong Hu, Ying Ren et al.· Human Mutation· 0 citations
This study may expand the mutation and phenotypic spectrum of SETD1A-related disorders, establishing the relationship between SETD1A variants and isolated early-onset epilepsy without accompanying severe neurodevelopmental deficits, and highlighting the value of genetic testing in infants with unexplained epilepsy.
Rina Su, Lei Zhu, Lin Jiang et al.· Frontiers in Neuroscience· 0 citations
A case series of an additional 13 affected individuals with RNF13 variants (2 missense, 11 truncating) supports and broadens previous reports and helps to define a narrow but critical region of the protein that is intolerant to truncating variation, although the gene is not highly constrained.
D. Latner, S. Hiatt, C. Finnila et al.· American Journal of Medical...· 0 citations
The identification of both novel and previously reported pathogenic variants expands the mutational spectrum of PURA and underscores the importance of integrating clinical, molecular, and bioinformatic data for accurate variant interpretation.
A. Madej-Pilarczyk, Marzena Gawlik, Beata Chałupczyńska et al.· Genes· 0 citations